Single nucleotide polymorphism in the low-density lipoprotein receptor is associated with a threefold risk of stroke. A case-control and prospective study.

[1]  A. Wu,et al.  Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. , 2001, The American journal of cardiology.

[2]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[3]  R. Frikke-Schmidt,et al.  APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease , 2001, Neurology.

[4]  P. Schnohr,et al.  Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. , 2000, Journal of lipid research.

[5]  H. Markus,et al.  Genetics and ischaemic stroke. , 2000, Brain : a journal of neurology.

[6]  P. Schnohr,et al.  A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men. , 2000, Circulation.

[7]  O. Faergeman,et al.  Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia. , 1999, Atherosclerosis.

[8]  J. B. Martin,et al.  Molecular basis of the neurodegenerative disorders. , 1999, The New England journal of medicine.

[9]  J. Poirier,et al.  The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease , 1999, Neuroscience Letters.

[10]  Steven M. Horvath,et al.  Alpha-2 macroglobulin is genetically associated with Alzheimer disease , 1998, Nature Genetics.

[11]  J. Gliemann,et al.  Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. , 1998, Biological chemistry.

[12]  B. Hyman,et al.  Confirmation of an association between a polymorphism in exon 3 of the low‐density lipoprotein receptor‐related protein gene and Alzheimer's disease , 1998, Neurology.

[13]  O. Khorkova,et al.  α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation , 1998 .

[14]  S. DeKosky,et al.  Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene , 1998, Neuroscience Letters.

[15]  B. Nordestgaard,et al.  ACE Gene Polymorphism as a Risk Factor for Ischemic Cerebrovascular Disease , 1997, Annals of Internal Medicine.

[16]  J. Goldstein,et al.  LDL-receptor structure: Calcium cages, acid baths and recycling receptors , 1997, Nature.

[17]  N. Relkin,et al.  Apolipoprotein E genotyping in Alzheimer's disease , 1996, The Lancet.

[18]  I. Kanazawa,et al.  Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease , 1995, Nature Genetics.

[19]  B. Hyman,et al.  LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation , 1995, Cell.

[20]  V. Gudnason,et al.  Effect of the StuI polymorphism in the LDL receptor gene (Ala 370 to Thr) on lipid levels in healthy individuals , 1995, Clinical genetics.

[21]  A. Schwartz,et al.  The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Boysen,et al.  Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study , 1994, BMJ.

[23]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[24]  M. Brown,et al.  Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. , 1992, The Journal of biological chemistry.

[25]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[26]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[27]  R. Cecchelli,et al.  Low‐Density Lipoprotein Receptor on Endothelium of Brain Capillaries , 1989, Journal of neurochemistry.

[28]  R. E. Pitas,et al.  Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. , 1987, The Journal of biological chemistry.

[29]  D. Russell,et al.  mRNA for low density lipoprotein receptor in brain and spinal cord of immature and mature rabbits. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Richard G. W. Anderson,et al.  Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region , 1987, Nature.

[31]  P. Brink,et al.  A DNA polymorphism in the human low-density lipoprotein receptor gene. , 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[32]  T. Südhof,et al.  The LDL receptor gene: a mosaic of exons shared with different proteins. , 1985, Science.

[33]  D. Russell,et al.  The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA , 1984, Cell.

[34]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[35]  P. Schnohr.  The Copenhagen City Heart Study : Østerbroundersøgelsen : tables with data from the third examination 1991-1994 , 2001 .

[36]  M. Fortini,et al.  Notch signaling. , 1995, Science.

[37]  Kenji Matsuno,et al.  Notch signaling. , 1995, Science.

[38]  E. B. Andersen,et al.  Logistic Regression Analysis , 1994 .

[39]  Hj Norussis,et al.  SPSS for Windows , 1993 .

[40]  The Copenhagen City Heart Study. Osterbroundersøgelsen. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). The Copenhagen City Heart Study Group. , 1989, Scandinavian journal of social medicine. Supplementum.

[41]  T. Farag,et al.  Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.